Cardiac Outcome Measures in Children With Muscular Dystrophy
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01066455 |
Recruitment Status
:
Completed
First Posted
: February 10, 2010
Last Update Posted
: January 11, 2013
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Duchenne Muscular Dystrophy Becker Muscular Dystrophy Limb Girdle Muscular Dystrophy |
The research study will include 50 participants aged 8 to 18 years old (before 18th birthday) with Duchenne, Becker, or autosomal recessive limb-girdle (specifically: LGMD 2C-2F and 2I) muscular dystrophies.
Participants will be seen in one of five Cooperative International Neuromuscular Research Group (CINRG) centers located in the United States.
All study assessments will be completed in the same day and include reviewing past medical and surgical history, collecting vital signs, collecting cardiac measures through echocardiographic tests.
Study Type : | Observational |
Actual Enrollment : | 48 participants |
Observational Model: | Case-Only |
Time Perspective: | Cross-Sectional |
Official Title: | PITT1109: Cardiac Outcome Measures in Children With Muscular Dystrophy |
Study Start Date : | January 2010 |
Actual Primary Completion Date : | May 2012 |
Actual Study Completion Date : | May 2012 |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 8 Years to 18 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Participants must be between the ages of 8 and 18 years old
- Confirmed diagnosis of muscular dystrophy (DMD, BMD, or LGMD 2C-2F and 2I)
Exclusion Criteria:
- Investigator assessment of inability to comply with protocol
- History of a congenital cardiac defect or other cardiac disease unrelated to muscular dystrophy

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01066455
United States, California | |
University of California Davis | |
Sacramento, California, United States | |
United States, District of Columbia | |
Children's National Medical Center | |
Washington, District of Columbia, United States | |
United States, Missouri | |
Washington University St. Louis | |
St. Louis, Missouri, United States | |
United States, Pennsylvania | |
University of Pittsburgh | |
Pittsburgh, Pennsylvania, United States, 15213 | |
United States, Texas | |
Texas Children's Hospital | |
Houston, Texas, United States |
Responsible Party: | Cooperative International Neuromuscular Research Group |
ClinicalTrials.gov Identifier: | NCT01066455 History of Changes |
Other Study ID Numbers: |
PITT1109 |
First Posted: | February 10, 2010 Key Record Dates |
Last Update Posted: | January 11, 2013 |
Last Verified: | January 2013 |
Keywords provided by Cooperative International Neuromuscular Research Group:
Cardiac Muscular Dystrophy Prospective Pediatric Echocardiogram |
Additional relevant MeSH terms:
Muscular Dystrophies Muscular Dystrophy, Duchenne Muscular Dystrophies, Limb-Girdle Muscular Disorders, Atrophic Muscular Diseases |
Musculoskeletal Diseases Neuromuscular Diseases Nervous System Diseases Genetic Diseases, Inborn Genetic Diseases, X-Linked |